Crossref
EFFICIENCY AND SAFETY OF USING PIDOTIMOD IN VACCINATED RISK GROUP CHILDREN
Pediatric pharmacology · 2013
DOI: 10.15690/pf.v10i1.591 ↗Kurz gefasst
Fachartikel in der Zeitschrift Pediatric pharmacology, 2013. Verfasst von A. A. Ruleva und 3 weiteren Autor:innen.
Themen: Kinderkrankenpflege
Abstract (Originalsprache)
Kein Abstract verfügbar.
Zitieren
APA
Ruleva, A. A., Kharit, S. M., Nacharova, E. P., & Fridman, I. V. (2013). EFFICIENCY AND SAFETY OF USING PIDOTIMOD IN VACCINATED RISK GROUP CHILDREN. Pediatric pharmacology. https://doi.org/10.15690/pf.v10i1.591
Vancouver
Ruleva AA, Kharit SM, Nacharova EP, Fridman IV. EFFICIENCY AND SAFETY OF USING PIDOTIMOD IN VACCINATED RISK GROUP CHILDREN. Pediatric pharmacology. 2013. doi:10.15690/pf.v10i1.591
BibTeX
@article{Ruleva2013,
author = {Ruleva, A. A. and Kharit, S. M. and Nacharova, E. P. and Fridman, I. V.},
title = {EFFICIENCY AND SAFETY OF USING PIDOTIMOD IN VACCINATED RISK GROUP CHILDREN},
journal = {Pediatric pharmacology},
year = {2013},
doi = {10.15690/pf.v10i1.591}
}
EUVIMED